Chengdu Easton Biopharmaceuticals (688513.SH): Methylene blue injection receives FDA drug registration approval in the United States.

17:00 24/12/2025

Yuandong Biological (688513.SH) announced that its wholly-owned subsidiary, Chengdu Shuode Pharmaceutical Co., Ltd. (referred to as "Shuode Pharmaceutical"), recently received a notice from the U.S. Food and Drug Administration (FDA). Shuode Pharmaceutical's Abbreviated New Drug Application (ANDA) for methylene blue injection, which was submitted to the FDA, has been officially approved.

Chengdu Easton Biopharmaceuticals (688513.SH) announced that its wholly-owned subsidiary Chengdu Shuode Pharmaceuticals Co., Ltd. ("Shuode Pharmaceuticals") recently received notification from the U.S. Food and Drug Administration ("FDA") that its Abbreviated New Drug Application (ANDA) for Methylene Blue Injection has been formally approved. The active ingredient of Methylene Blue Injection is methylene blue, indicated for the treatment of acquired methemoglobinemia in children and adults.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"